Bicara Therapeutics Inc (BCAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 41,122 | 40,676 | 32,018 | 41,788 | 26,637 |
| Operating Income | -41,122 | -40,676 | -32,018 | -41,788 | -26,637 |
| Other Income | 3,789 | 4,386 | 4,682 | 5,014 | 5,866 |
| Pre-tax Income | -37,333 | -36,290 | -27,336 | -36,774 | -20,771 |
| Income Tax | 53 | 40 | 52 | 72 | 186 |
| Net Income Continuous | -37,386 | -36,330 | -27,388 | -36,846 | -20,957 |
| Net Income | $-37,386 | $-36,330 | $-27,388 | $-36,846 | $-20,957 |
| EPS Basic Total Ops | -0.67 | -0.67 | -0.50 | -0.68 | 35.50 |
| EPS Basic Continuous Ops | -0.68 | -0.67 | -0.50 | -0.68 | 35.52 |
| EPS Diluted Total Ops | -0.67 | -0.67 | -0.50 | -0.68 | 35.50 |
| EPS Diluted Continuous Ops | -0.68 | -0.67 | -0.50 | -0.68 | 35.52 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.67 | -0.50 | -0.68 | -0.39 |
| EBITDA(a) | $-40,810 | $-40,620 | $-31,999 | $-41,769 | $-26,622 |